PROGRESS: Implementation of a novel hybrid decentralized clinical trial to support precision oncology uptake at academic and community oncology practices in North Carolina.
Meghan McGonagle, Stephanie Drotts, Jaime Richardson, Kevin Yanjun Chen et autres
e23150 Background: Rates of comprehensive molecular profiling (CMP), use of evidence-based genome-informed therapy (GIT), and clinical trial participation remain low in real-world data sets. We designed an interventional clinical trial (PROGRESS) using decentralized methodology to evaluate the impact of a centralized precision …
us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology